Donna Roy Grogan C4 Therapeutics, Inc. (CCCC) insider trading activity

Donna Roy Grogan is Director of C4 Therapeutics, Inc.. Currently has a direct ownership of 26,468 shares of CCCC, which is worth approximately $154,308. The most recent transaction as insider was on Jul 01, 2024, when has been sold 2,836 shares (Common Stock) at a price of $4.85 per share, resulting in proceeds of $13,754. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.5K

12.0% 3M change

125.49% 12M change

Total Value Held $154,308

DONNA ROY GROGAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 01 2024	BUY Grant, award, or other acquisition	$13,754 $4.85 p/Share	2,836 Added 9.68%	26,468 Common Stock
Apr 01 2024	BUY Grant, award, or other acquisition	$13,745 $8.1 p/Share	1,697 Added 6.7%	23,632 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	$13,744 $6.52 p/Share	2,108 Added 8.77%	21,935 Common Stock
Oct 02 2023	BUY Grant, award, or other acquisition	$13,751 $1.7 p/Share	8,089 Added 28.98%	19,827 Common Stock
Jul 03 2023	BUY Grant, award, or other acquisition	$13,748 $2.83 p/Share	4,858 Added 29.27%	11,738 Common Stock
Apr 03 2023	BUY Grant, award, or other acquisition	$13,753 $3.2 p/Share	4,298 Added 38.45%	6,880 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	$11,247 $6.38 p/Share	1,763 Added 40.58%	2,582 Common Stock
Oct 03 2022	BUY Grant, award, or other acquisition	$7,117 $8.69 p/Share	819 Added 50.0%	819 Common Stock

DRG

Donna Roy Grogan

Director

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Value

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

Operation

Value

Type

News

Receive news related to C4 Therapeutics, Inc.

Track Activities on CCCC

Account